Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quanergy Systems Inc. QNGY

Quanergy Systems Inc offers a high-performance AI-powered LiDAR platform designed to accelerate the automation of key business processes to increase productivity, efficiency, and safety of 3D world.


NYSE:QNGY - Post by User

Comment by Iseneschalon Oct 28, 2022 10:41am
26 Views
Post# 35055784

RE:QNGY....u should do some research on this ; )

RE:QNGY....u should do some research on this ; )
Iseneschal wrote: It used to be a "Spac"....Special Purpose Acquisition Co... $10 IPO

 

Quanergy Systems Announces Closing of Business Combination

 

2022-02-08 16:53 ET - News Release

 

Quanergy begins trading on the NYSE under Ticker “QNGY” tomorrow, February 9, 2022

Transaction Proceeds and Committed Funding of $175 Million Position Company for Continued Growth


Company Website: https://www.quanergy.com
SUNNYVALE, Calif. -- (Business Wire)

Quanergy Systems, Inc. (the “Company”), a leading provider of OPA-based solid state LiDAR sensors and smart 3D solutions for automotive and IoT, today announced the closing of its previously announced business combination with CITIC Capital Acquisition Corp. (“CCAC”) (NYSE: CCAC), a publicly traded special purpose acquisition company. The transaction gives the Company access to approximately $175 million in available liquidity on top of its existing balance sheet, before transaction expenses and debt paydown, consisting of approximately $50 million in cash proceeds from the PIPE and SPAC Trust, as well as up to $125 million in committed funding from a previously announced share subscription facility from Global Emerging Markets Group (“GEM”), a Luxembourg-based private alternative investment group. Under the GEM facility, the Company can draw on a $25 million advance from the total $125M following effectiveness of a resale S-1 Registration Statement. Proceeds from the transaction will be used for working capital, repayment of $35 million of secured notes, and transaction expenses, positioning the Company to fund future growth and continue investing in its leading portfolio of smart LiDAR and 3D perception solutions.

This press release features multimedia. View the full release here:



09:29:17 EDT Fri 28 Oct 2022
Enter Symbol
or Name
 USA
 CA



You are logged in: sl1scorpio
 

 

SciSparc: Wellution(TM) Successfully Launched a New Keto Gummies Apple Cider Vinegar Product and Generated $100,000 In Revenues Within 30 Days

 

2022-10-28 04:45 ET - News Release

 

Since launch the new product has had approximately 117% ROI

TEL AVIV, Israel, Oct. 28, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that SciSparc Nutraceuticals Inc., its wholly owned subsidiary, has successfully launched a new keto gummies apple cider vinegar product under its brand Wellution(TM) on Amazon.com.

In the 30 days following the launch, the new product has generated more than $100,000 in revenues with an ROI (return on investment after costs of goods, marketing, advertising, shipping, storage and commissions) to the Company of approximately 117%.

"Our expansion plans for the WellutionTM brand include launching new products that will appeal to current and future customers. In the first 30 days since its launch, this new product has achieved impressive results and we are pleased with its success so far," Oz Adler, SciSparc's Chief Executive Officer, commented. "To continue expanding the Wellution's reach, we intend to develop new attractive products, either independently or in collaboration with third parties, while reducing production and supply chain costs and exploring new markets and sales channels."

View the product at: https://www.amazon.com/Keto-Gummies-Apple-Cider-Vinegar/dp/B0B4ST8TZQ?ref_=ast_sto_dp

About SciSparc Ltd. (NASDAQ: SPRC):

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc's focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and status epilepticus.

SciSparc also owns Wellution(TM), a brand that sells dozens of hemp-based products, including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. Wellution(TM) offers eight variations of natural hemp candy supplements under two parent Amazon Standard Identification Numbers ("ASINs") on Amazon that are differentiated by their hemp oil potency. The leading parent ASIN, which was launched in 2019, has received over 26,500 reviews and is consistently ranked as the #1 best seller in the category. In total, the brand has over 40,000 product reviews, most of which are 4 and 5-star reviews.





<< Previous
Bullboard Posts
Next >>